Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Accelerated Review Options (AROs)
-
Good Morning @agency and @manufacturer
The highly anticipated Accelerated Review Options (AROs) Planned Features Document is now available for your viewing pleasure.
Learn about the proposed features and how the roll out is set to start. Feel free to reach out with any questions by posting questions and comments in this section of the Forum.
We look forward to growing this new set of review options with you!
